Sonoma Pharmaceuticals (SNOA) Operating Leases (2019 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Operating Leases of $509000.0 in Q4 2025, up 6.26% quarter-over-quarter from $479000.0 in Q3 2025, and up 327.73% on a YoY basis from $119000.0 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) Operating Leases (2019 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' Operating Leases history runs 7 years deep, the most recent figure standing at $509000.0 for Q4 2025.
- In Q4 2025, Operating Leases rose 327.73% year-over-year to $509000.0; the TTM figure through Dec 2025 stood at $509000.0 (up 327.73% YoY), while the FY2025 annual figure was $27000.0, down 68.97% from the prior year.
- Operating Leases was $509000.0 for Q4 2025 at Sonoma Pharmaceuticals, up from $479000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $722000.0 in Q2 2021 to a low of $27000.0 in Q1 2025.
- Historically, Operating Leases has averaged $331700.0 across 5 years, with a median of $345500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Operating Leases plunged 82.77% in 2024, then jumped 621.31% in 2025.
- A 5-year view of Operating Leases shows it stood at $362000.0 in 2021, then tumbled by 46.13% to $195000.0 in 2022, then surged by 74.87% to $341000.0 in 2023, then sank by 65.1% to $119000.0 in 2024, then jumped by 327.73% to $509000.0 in 2025.
- The last three Operating Leases figures came in at $509000.0 (Q4 2025), $479000.0 (Q3 2025), and $440000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 509,000.00 |
| Sep 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 440,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 119,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 341,000.00 |
| Sep 30, 2023 | 350,000.00 |
| Jun 30, 2023 | 354,000.00 |
| Mar 31, 2023 | 162,000.00 |
| Dec 31, 2022 | 195,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Jun 30, 2022 | 478,000.00 |
| Mar 31, 2022 | 309,000.00 |
| Dec 31, 2021 | 362,000.00 |
| Sep 30, 2021 | 700,000.00 |
| Jun 30, 2021 | 722,000.00 |
| Mar 31, 2021 | 529,000.00 |